Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
about
The use of lentinan for treating gastric cancerLentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapyPhase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancerPhase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma.Targeted therapies for gastric cancer: current status.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysisRefining docetaxel-containing therapy for gastric cancer.Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.Chemotherapy for advanced gastric cancer: review of global and Japanese status.The role of S-1 in the treatment of gastric cancer.Capecitabine in the treatment of advanced gastric cancer.Diverse eastern and Western approaches to the management of gastric cancer.Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START).A case of advanced gastric cancer achieved a pathological complete response by chemotherapy.Chemotherapy for advanced gastric cancer: a new milestone lies ahead.Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial.Cardiac tamponade due to metastasis from early gastric cancer.Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.
P2860
Q24619416-ACFEBE07-9570-4D6D-A1ED-5844779D663EQ24635111-9AADC978-9DCF-46E1-A916-9AA4713F9040Q33390208-75633A7F-C415-42B3-9DEA-00E19FF63298Q33403640-2F6CE34C-4209-46E8-8A12-95F36F96C70BQ33425150-A5A2ADA3-EC9F-4AA2-B0D7-B5CEDB898D9AQ34205672-E5D6D265-F4CE-4CA0-A461-5374B9DC07FFQ34450648-AC31460B-3DD6-40F4-845E-8EE437658B8AQ34672942-73F4EBA4-4264-4929-92C6-83FA0310A39AQ35445166-AE7B93FB-4B8B-47A1-A41B-70FB95F0F502Q36117215-6FE422FB-DEF3-434B-88BF-163D5BD8632FQ36453663-DC82020D-38DF-48C8-9E89-6A7607F6160DQ36611262-028EA29C-AD1A-4CFB-8F02-7B2E0C10246BQ36612612-A8DB1BD3-1C27-4B7F-91DC-CAA86D73026CQ36615597-3D72A03A-149C-4A74-BE2B-9E77D8DDBC11Q36795339-5286CD4C-AC42-4DD5-AD50-7BD9AE5965CCQ37076553-A76A457E-5E63-4BB8-80E9-05904AC2033EQ37117556-6522EDD9-9162-487B-93AA-03FD89B384FCQ37136996-5D2FF25F-D1C9-4E60-BC1F-E2D49A3C32DCQ37141671-976DE129-DC92-435D-995F-F4AC2C0A52FBQ37491365-588E36C3-9EF4-437B-97C7-CD1676B1F31DQ42271670-16D55D75-8BFD-4E83-9C66-F15E6D62A60BQ42282836-1A565C92-E26E-442A-9B2B-E9E41EC5D578Q45435712-41D66011-158B-4AB7-A048-71346CEC8A84Q48052472-E01C97EA-154F-4709-8C80-48331FD70222Q51284727-5ED88348-74C2-492E-98A0-33A9E6BDBA24Q53803365-28DCB09A-3815-48B7-97CA-332BC698147D
P2860
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@ast
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@en
type
label
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@ast
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@en
prefLabel
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@ast
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@en
P2093
P2860
P356
P1476
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
@en
P2093
H Narahara
H Takiuchi
K Yamaguchi
M Munakata
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603196
P407
P577
2006-06-01T00:00:00Z
P5875
P6179
1024588610